Abbott Laboratories (ABT) : Zacks Investment Research ranks Abbott Laboratories (ABT) as 3, which is a Hold recommendation. 10 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 other analysts are mildly bullish on the stock and favor a Buy. A total of 4 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 15 research analysts is 1.6, which indicates as a Buy.
Abbott Laboratories (ABT) : Average target price received by Abbott Laboratories (ABT) is $48.82 with an expected standard deviation of $1.78. The most aggressive target on the stock is $52, whereas the most downbeat target is $45. 11 financial analysts are currently covering the stock.
Abbott Laboratories has dropped 2.27% in the last five trading days, however, the shares have posted positive gains of 1.13% in the last 4 weeks. Abbott Laboratories is up 16.3% in the last 3-month period. Year-to-Date the stock performance stands at -0.42%. Abbott Laboratories (NYSE:ABT): On Tuesdays trading session , Opening price of the stock was $44.37 with an intraday high of $44.42. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $43.9. However, the stock managed to close at $43.9, a loss of 0.61% for the day. On the previous day, the stock had closed at $44.17. The total traded volume of the day was 7,401,381 shares.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a range of health care products. Abbott operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.